KR880012629A - 신규 리보푸라누론산 유도체 - Google Patents

신규 리보푸라누론산 유도체 Download PDF

Info

Publication number
KR880012629A
KR880012629A KR1019880003819A KR880003819A KR880012629A KR 880012629 A KR880012629 A KR 880012629A KR 1019880003819 A KR1019880003819 A KR 1019880003819A KR 880003819 A KR880003819 A KR 880003819A KR 880012629 A KR880012629 A KR 880012629A
Authority
KR
South Korea
Prior art keywords
deoxy
furinyl
alkyl
ribofuranuronic acid
ethylamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1019880003819A
Other languages
English (en)
Korean (ko)
Inventor
가디엔트 풀비오
보겔 아놀드
Original Assignee
예안 클라메르,한스 루돌프 하우스
산도즈 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 예안 클라메르,한스 루돌프 하우스, 산도즈 리미티드 filed Critical 예안 클라메르,한스 루돌프 하우스
Publication of KR880012629A publication Critical patent/KR880012629A/ko
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
KR1019880003819A 1987-04-06 1988-04-04 신규 리보푸라누론산 유도체 Ceased KR880012629A (ko)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
DE3711562 1987-04-06
DE3711561 1987-04-06
CHP3711563.4 1987-04-06
DE3711563 1987-04-06
CHP3711562.6 1987-04-06
CHP3711561.8 1987-04-06
CHP3711564.2 1987-04-06
DE3711564 1987-04-06

Publications (1)

Publication Number Publication Date
KR880012629A true KR880012629A (ko) 1988-11-28

Family

ID=27433888

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019880003819A Ceased KR880012629A (ko) 1987-04-06 1988-04-04 신규 리보푸라누론산 유도체

Country Status (22)

Country Link
JP (1) JPS63258892A (enrdf_load_stackoverflow)
KR (1) KR880012629A (enrdf_load_stackoverflow)
AT (1) AT393507B (enrdf_load_stackoverflow)
AU (1) AU609109B2 (enrdf_load_stackoverflow)
BE (1) BE1002151A5 (enrdf_load_stackoverflow)
CA (1) CA1326017C (enrdf_load_stackoverflow)
CH (1) CH676121A5 (enrdf_load_stackoverflow)
DK (1) DK183488A (enrdf_load_stackoverflow)
ES (1) ES2007177A6 (enrdf_load_stackoverflow)
FI (1) FI87463C (enrdf_load_stackoverflow)
FR (1) FR2613367A1 (enrdf_load_stackoverflow)
GB (1) GB2203149B (enrdf_load_stackoverflow)
HU (1) HU201955B (enrdf_load_stackoverflow)
IL (1) IL85969A (enrdf_load_stackoverflow)
IT (1) IT1219892B (enrdf_load_stackoverflow)
LU (1) LU87181A1 (enrdf_load_stackoverflow)
MY (1) MY102323A (enrdf_load_stackoverflow)
NL (1) NL8800862A (enrdf_load_stackoverflow)
NZ (1) NZ224131A (enrdf_load_stackoverflow)
PH (1) PH25424A (enrdf_load_stackoverflow)
PT (1) PT87153B (enrdf_load_stackoverflow)
SE (1) SE8801236L (enrdf_load_stackoverflow)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4755594A (en) * 1986-01-31 1988-07-05 Warner-Lambert Company N6 -substituted adenosines
US4954504A (en) * 1986-11-14 1990-09-04 Ciba-Geigy Corporation N9 -cyclopentyl-substituted adenine derivatives having adenosine-2 receptor stimulating activity
US5063233A (en) * 1986-11-14 1991-11-05 Ciba-Geigy Corporation N9 -cyclopentyl-substituted adenine derivatives useful as adenosine receptor agonists
HU198950B (en) * 1986-12-15 1989-12-28 Sandoz Ag Process for producing new furanuronic acid derivatives and pharmaceutical compositions comprising such compounds
EP0277917A3 (en) * 1987-02-04 1990-03-28 Ciba-Geigy Ag Certain adenosine 5'-carboxamide derivatives
US4968697A (en) * 1987-02-04 1990-11-06 Ciba-Geigy Corporation 2-substituted adenosine 5'-carboxamides as antihypertensive agents
US5140015A (en) * 1990-02-20 1992-08-18 Whitby Research, Inc. 2-aralkoxy and 2-alkoxy adenosine derivatives as coronary vasodilators and antihypertensive agents
USRE36494E (en) * 1990-02-20 2000-01-11 Discovery Therapeutics, Inc. 2-aralkoxy and 2-alkoxy adenosine derivatives as coronary vasodilators and antihypertensive agents
IT1254915B (it) * 1992-04-24 1995-10-11 Gloria Cristalli Derivati di adenosina ad attivita' a2 agonista
GB9301000D0 (en) * 1993-01-20 1993-03-10 Glaxo Group Ltd Chemical compounds
TW528755B (en) 1996-12-24 2003-04-21 Glaxo Group Ltd 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
YU44900A (sh) 1998-01-31 2003-01-31 Glaxo Group Limited Derivati 2-(purin-9-il)tetrahidrofuran-3,4-diola
CZ20004868A3 (cs) 1998-06-23 2001-08-15 Glaxo Group Limited 2-(Purin-9-yl)-tetrahydrofuran-3,4-diolové deriváty, způsob jejich přípravy a fármaceutické prostředky, které je obsahují
AU4343500A (en) 1999-04-16 2000-11-02 Schering Corporation Use of azetidinone compounds
US20050033044A1 (en) 2003-05-19 2005-02-10 Bristol-Myers Squibb Pharma Company Methods for preparing 2-alkynyladenosine derivatives
AR049384A1 (es) 2004-05-24 2006-07-26 Glaxo Group Ltd Derivados de purina
ATE531377T1 (de) * 2004-09-20 2011-11-15 Inotek Pharmaceuticals Corp Purin-derivate und anwendungsverfahren
GB0514809D0 (en) 2005-07-19 2005-08-24 Glaxo Group Ltd Compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH606084A5 (en) * 1975-02-18 1978-10-13 Hoffmann La Roche (Di) nitrates of adenosine -5'-carboxylic acid derivs
US4167565A (en) * 1976-11-08 1979-09-11 Abbott Laboratories Adenosine-5'-carboxamides and method of use
DE3406533A1 (de) * 1984-02-23 1985-08-29 Boehringer Mannheim Gmbh, 6800 Mannheim Verwendung von adenosin-derivaten als antiallergica und arzneimittel, die diese enthalten
HU198950B (en) * 1986-12-15 1989-12-28 Sandoz Ag Process for producing new furanuronic acid derivatives and pharmaceutical compositions comprising such compounds
EP0277917A3 (en) * 1987-02-04 1990-03-28 Ciba-Geigy Ag Certain adenosine 5'-carboxamide derivatives

Also Published As

Publication number Publication date
GB8807750D0 (en) 1988-05-05
FI881571A0 (fi) 1988-04-05
HU201955B (en) 1991-01-28
PH25424A (enrdf_load_stackoverflow) 1991-07-01
NZ224131A (en) 1991-12-23
DK183488D0 (da) 1988-04-05
PT87153A (pt) 1988-05-01
IT1219892B (it) 1990-05-24
SE8801236A0 (sv) 1988-10-17
DK183488A (da) 1988-10-07
IL85969A (en) 1992-03-29
SE8801236D0 (sv) 1988-04-05
AU1415188A (en) 1988-10-06
FR2613367A1 (fr) 1988-10-07
NL8800862A (nl) 1988-11-01
MY102323A (en) 1992-05-28
FI87463B (fi) 1992-09-30
BE1002151A5 (fr) 1990-08-07
ATA87388A (de) 1991-04-15
AT393507B (de) 1991-11-11
GB2203149A (en) 1988-10-12
LU87181A1 (fr) 1988-11-17
ES2007177A6 (es) 1989-06-01
CA1326017C (en) 1994-01-11
JPS63258892A (ja) 1988-10-26
AU609109B2 (en) 1991-04-26
PT87153B (pt) 1992-07-31
IT8847794A0 (it) 1988-03-30
FI881571L (fi) 1988-10-07
CH676121A5 (enrdf_load_stackoverflow) 1990-12-14
SE8801236L (sv) 1988-10-17
HUT48902A (en) 1989-07-28
FI87463C (fi) 1993-01-11
GB2203149B (en) 1991-02-13
IL85969A0 (en) 1988-09-30

Similar Documents

Publication Publication Date Title
KR880012629A (ko) 신규 리보푸라누론산 유도체
RU2002107975A (ru) Глюкопиранозилоксипиразольные производные, лекарственные композиции, содержащие эти производные, и промежуточные соединения для их получения
KR890003742A (ko) 카르바모일키롤리돈 유도체 및 노인성 치매용 약제
RU96115142A (ru) Производные 5-(2-имидазолиниламино)бензимидазола, их получение и применение в качестве агонистов альфа-2-адреноцепторов
KR910004581A (ko) 신규 화합물들
RU2007124329A (ru) ПРОИЗВОДНЫЕ 5-ГИДРОКСИБЕНЗОТИАЗОЛА В КАЧЕСТВЕ АГОНИСТОВ β2 АДРЕНОРЕЦЕПТОРОВ
KR910015552A (ko) 항당뇨병성 활성을 가진 티아졸리딘 유도체, 그의 제조 방법 및 용도
DK162519C (da) Dihydropyridazinonderivater og fremgangsmaade til fremstilling deraf samt farmaceutisk praeparat indeholdende forbindelserne
DE69006984D1 (de) Thiazolidinedionederivate.
RU97119064A (ru) Применение альфа(il)-агонистов для лечения недержания мочи
KR930702288A (ko) 타이졸리딘디온 유도체
KR890014534A (ko) 혈당 감소제로서 티아졸리딘디온 유도체
KR960007592A (ko) 신규한 피롤로카바졸
KR890000477A (ko) 신규 화합물들
KR930004262A (ko) 메타노안트라센 화합물
PT82897B (pt) Processo de preparacao de derivados de di-hidropiridazinona
KR900014396A (ko) 티에노-트리아졸로-디아제핀 유도체, 그의 제조 방법 및 그를 함유하는 치료 조성물
KR910000614A (ko) 신규 화합물
AR012991A1 (es) Compuestos utiles para la inhibicion de transferasa de proteina al farnesilo y su uso para la preparacion de medicamentos.
RU2004126320A (ru) Производные имидазо [1,2-а]пиридина
KR910004559A (ko) 중추 신경계에 작용하는 무스카린성 약제인 4-(n-치환 아미노)-2-부티닐-1-우레아 및 티오우레아와 그의 유도체
KR960706476A (ko) 인터류킨-1 활성 억제제로서의 신규한 벤젠설포닐아민 유도체(Novel benzen-esulfonylimine derivatives as inhibitors of lL-1 action)
KR910006219A (ko) 벤즈아닐리드 유도체 및 그의 제조방법
KR900016178A (ko) 2-치환 n,n'-디트리메톡시벤조일 피페라진, 그의 제조 방법 및 그를 함유하는 치료 조성물
KR910002821A (ko) 1,5-벤조티아제핀 유도체, 그의 제조 방법 및 심장혈관 질환의 치료시 용도

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19880404

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19930325

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19880404

Comment text: Patent Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19960919

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 19961210

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 19960919

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I